CN108642718A - A kind of dressing for testing patients with gestational diabetes blood glucose - Google Patents
A kind of dressing for testing patients with gestational diabetes blood glucose Download PDFInfo
- Publication number
- CN108642718A CN108642718A CN201810440809.4A CN201810440809A CN108642718A CN 108642718 A CN108642718 A CN 108642718A CN 201810440809 A CN201810440809 A CN 201810440809A CN 108642718 A CN108642718 A CN 108642718A
- Authority
- CN
- China
- Prior art keywords
- solution
- dressing
- parts
- powder
- blood glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D1/00—Treatment of filament-forming or like material
- D01D1/02—Preparation of spinning solutions
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0069—Electro-spinning characterised by the electro-spinning apparatus characterised by the spinning section, e.g. capillary tube, protrusion or pin
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0076—Electro-spinning characterised by the electro-spinning apparatus characterised by the collecting device, e.g. drum, wheel, endless belt, plate or grid
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
- D04H1/4382—Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Mechanical Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
Abstract
The present invention provides a kind of dressing for testing patients with gestational diabetes blood glucose, it is characterised in that：Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved in deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is dissolved in hexafluoroisopropanol, third solution is obtained；The first solution and the second solution are added dropwise into third solution, and carries out the first stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out the second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into electrostatic spinning syringe, and dressing is prepared using electrospinning process.The present invention proposes a kind of new pattern compress, and this dressing good permeability, intensity height, soft, good biocompatibility will not cause patient uncomfortable.
Description
Technical field
The present invention relates to medical material field, more particularly to a kind of dressing for testing patients with gestational diabetes blood glucose.
Background technology
The patient's gestation for having diabetes before gestation, claims pregnancy in women with diabetes mellitus；Another kind is normal for glycometabolism before gestation
Or having potential impaired glucose tolerance, just there are diabetes, also known as gestational diabetes (GDM) in the gestational period.In pregnant diabetic women
80% or more is GDM, and pregnancy in women with diabetes mellitus person is less than 20%.GDM patient's glycometabolism majority can restore normal in postpartum, but will
Increase to suffer from diabetes B chance.The clinical of pregnant diabetic women passes through complexity.There is larger harm to female youngster, it is necessary to cause weight
Depending on.Gestational diabetes mellitus screening method mainly has：1. urinary glucose determination.Glucose in urine positive only not consider gestational period physiological glycosuria,
Fasting blood-glucose inspection and sugared Screening tests should further be done.2. fasting plasma glucose.Twice or more than twice fasting blood-glucose >=
5.8mmol/L person, diagnosable is diabetes.3. sugared Screening tests.It is recommended that carrying out GDM screenings, 50g grapes within 24~28 weeks in gestation
Icing Sugar is dissolved in 200ml water, is taken in 5 minutes, and 1 hour thereafter blood glucose value >=7.8mmol/L is that sugared screening is positive, should check sky
Abdomen blood glucose, diagnosable impaired fasting glucose is diabetes, the normal person of fasting blood-glucose row dextrose tolerance test (OGTT) again.
Being disclosed in the information of the background technology part, it is only intended to increase understanding of the overall background of the invention, without answering
It has been the prior art well known to persons skilled in the art when being considered as recognizing or imply that the information is constituted in any form.
Invention content
It is existing to overcome the purpose of the present invention is to provide a kind of dressing for testing patients with gestational diabetes blood glucose
The shortcomings that technology.
To achieve the above object, special the present invention provides a kind of dressing for testing patients with gestational diabetes blood glucose
Sign is：Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved
In deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is molten
Solution obtains third solution in hexafluoroisopropanol；The first solution and the second solution are added dropwise into third solution, and carries out first
Stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out
Second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into quiet
Electrospun syringe, and prepare dressing using electrospinning process.
Preferably, in above-mentioned technical proposal, in the first solution, the mass percent of PVA powder is 4-6%.
Preferably, in above-mentioned technical proposal, in the second solution, the mass percent of polylactic acid is 3-5%.
Preferably, in above-mentioned technical proposal, in third solution, the mass percent of PAAS powder is 8-10%.
Preferably, in above-mentioned technical proposal, in parts by weight, in the 4th solution, PVA powder accounts for 10-12 parts, polylactic acid
3-5 parts are accounted for, PAAS powder accounts for 5-10 parts.
Preferably, in above-mentioned technical proposal, in parts by weight, in the 5th solution, PVA powder accounts for 100-120 parts, nanometer
Titanium dioxide accounts for 3-6 parts, and nano silver accounts for 1-3 parts.
Preferably, in above-mentioned technical proposal, irradiation is specially：Irradiation energy is 1-2MeV, electric current 5-10mA, when irradiation
Between be 10-20min.
Preferably, in above-mentioned technical proposal, electrostatic spinning concrete technology is：Using roller as wire drawing device, syringe needle and rolling
Distance is 10-12cm, drum rotation speed 900-1200rpm between cylinder, and voltage difference is 10-15V between syringe needle and roller.
Compared with prior art, the present invention has the advantages that：As previously mentioned, confirm with gestational diabetes mellitus or
Blood glucose is in the pregnant woman of critical value, needs to adhere to, periodically carries out blood sugar test, reliably diagnoses and control to provide science for doctor
Treat foundation.The common blood sugar test method of layman is that test refers to blood blood glucose at present, and it is simple to refer to blood blood sugar test, without special
Industry training, test result and tester's operation horizontal relationship are little.But refer to that blood test has the disadvantage that：Testing procedure is multiple
It is miscellaneous；Test hour hands often puncture operator's finger；Test paper is expensive.In order to overcome the defect for referring to blood and surveying blood glucose, have been developed for burying
The probe for entering upper arm can read blood glucose value at any time then in conjunction with NFC technique using mobile phone.This method ratio refers to blood test more
Fast, simpler.In order to fix probe, the sticking dressing at upper arm is needed, dressing is mostly expensive at present, poor air permeability, material
Matter is partially hard, causes patient's sticking dressing position very uncomfortable.In order to overcome the deficiencies of existing technologies, the present invention proposes a kind of new
Type dressing, this dressing good permeability, softness, good biocompatibility will not cause patient uncomfortable.
Specific implementation mode
It provides these embodiments to be to be able to be best understood from the disclosure, and can be complete by the scope of the present disclosure
Whole is communicated to those skilled in the art.
Embodiment 1
Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved
In deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is molten
Solution obtains third solution in hexafluoroisopropanol；The first solution and the second solution are added dropwise into third solution, and carries out first
Stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out
Second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into quiet
Electrospun syringe, and prepare dressing using electrospinning process.In the first solution, the mass percent of PVA powder is 4%.
In the second solution, the mass percent of polylactic acid is 3%.In third solution, the mass percent of PAAS powder is 8%.
In parts by weight, in the 4th solution, PVA powder accounts for 10 parts, and polylactic acid accounts for 3 parts, and PAAS powder accounts for 5 parts.In parts by weight, exist
In 5th solution, PVA powder accounts for 100 parts, and nano-titanium dioxide accounts for 3 parts, and nano silver accounts for 1 part.Irradiation is specially：Irradiation energy is
1MeV, electric current 5mA, irradiation time 20min.Electrostatic spinning concrete technology is：Using roller as wire drawing device, syringe needle and rolling
Distance is 10cm, drum rotation speed 900rpm between cylinder, and voltage difference is 10V between syringe needle and roller.
Embodiment 2
Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved
In deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is molten
Solution obtains third solution in hexafluoroisopropanol；The first solution and the second solution are added dropwise into third solution, and carries out first
Stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out
Second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into quiet
Electrospun syringe, and prepare dressing using electrospinning process.In the first solution, the mass percent of PVA powder is 6%.
In the second solution, the mass percent of polylactic acid is 5%.In third solution, the mass percent of PAAS powder is 10%.
In parts by weight, in the 4th solution, PVA powder accounts for 12 parts, and polylactic acid accounts for 5 parts, and PAAS powder accounts for 10 parts.In parts by weight,
In the 5th solution, PVA powder accounts for 120 parts, and nano-titanium dioxide accounts for 6 parts, and nano silver accounts for 3 parts.Irradiation is specially：Irradiation energy
For 2MeV, electric current 10mA, irradiation time 10min.Electrostatic spinning concrete technology is：Using roller as wire drawing device, syringe needle
Distance is 12cm, drum rotation speed 1200rpm between roller, and voltage difference is 15V between syringe needle and roller.
Embodiment 3
Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved
In deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is molten
Solution obtains third solution in hexafluoroisopropanol；The first solution and the second solution are added dropwise into third solution, and carries out first
Stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out
Second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into quiet
Electrospun syringe, and prepare dressing using electrospinning process.In the first solution, the mass percent of PVA powder is 5%.
In the second solution, the mass percent of polylactic acid is 4%.In third solution, the mass percent of PAAS powder is 9%.
In parts by weight, in the 4th solution, PVA powder accounts for 11 parts, and polylactic acid accounts for 4 parts, and PAAS powder accounts for 8 parts.In parts by weight, exist
In 5th solution, PVA powder accounts for 110 parts, and nano-titanium dioxide accounts for 4 parts, and nano silver accounts for 2 parts.Irradiation is specially：Irradiation energy is
1.5MeV, electric current 8mA, irradiation time 15min.Electrostatic spinning concrete technology is：Using roller as wire drawing device, syringe needle with
Distance is 11cm, drum rotation speed 1000rpm between roller, and voltage difference is 12V between syringe needle and roller.
Embodiment 4
Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved
In deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is molten
Solution obtains third solution in hexafluoroisopropanol；The first solution and the second solution are added dropwise into third solution, and carries out first
Stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out
Second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into quiet
Electrospun syringe, and prepare dressing using electrospinning process.In the first solution, the mass percent of PVA powder is 8%.
In the second solution, the mass percent of polylactic acid is 7%.In third solution, the mass percent of PAAS powder is 13%.
In parts by weight, in the 4th solution, PVA powder accounts for 11 parts, and polylactic acid accounts for 4 parts, and PAAS powder accounts for 8 parts.In parts by weight, exist
In 5th solution, PVA powder accounts for 110 parts, and nano-titanium dioxide accounts for 4 parts, and nano silver accounts for 2 parts.Irradiation is specially：Irradiation energy is
1.5MeV, electric current 8mA, irradiation time 15min.Electrostatic spinning concrete technology is：Using roller as wire drawing device, syringe needle with
Distance is 11cm, drum rotation speed 1000rpm between roller, and voltage difference is 12V between syringe needle and roller.
Embodiment 5
Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved
In deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is molten
Solution obtains third solution in hexafluoroisopropanol；The first solution and the second solution are added dropwise into third solution, and carries out first
Stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out
Second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into quiet
Electrospun syringe, and prepare dressing using electrospinning process.In the first solution, the mass percent of PVA powder is 5%.
In the second solution, the mass percent of polylactic acid is 4%.In third solution, the mass percent of PAAS powder is 9%.
In parts by weight, in the 4th solution, PVA powder accounts for 15 parts, and polylactic acid accounts for 2 parts, and PAAS powder accounts for 4 parts.In parts by weight, exist
In 5th solution, PVA powder accounts for 110 parts, and nano-titanium dioxide accounts for 4 parts, and nano silver accounts for 2 parts.Irradiation is specially：Irradiation energy is
1.5MeV, electric current 8mA, irradiation time 15min.Electrostatic spinning concrete technology is：Using roller as wire drawing device, syringe needle with
Distance is 11cm, drum rotation speed 1000rpm between roller, and voltage difference is 12V between syringe needle and roller.
Embodiment 6
Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved
In deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is molten
Solution obtains third solution in hexafluoroisopropanol；The first solution and the second solution are added dropwise into third solution, and carries out first
Stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out
Second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into quiet
Electrospun syringe, and prepare dressing using electrospinning process.In the first solution, the mass percent of PVA powder is 5%.
In the second solution, the mass percent of polylactic acid is 4%.In third solution, the mass percent of PAAS powder is 9%.
In parts by weight, in the 4th solution, PVA powder accounts for 11 parts, and polylactic acid accounts for 4 parts, and PAAS powder accounts for 8 parts.In parts by weight, exist
In 5th solution, PVA powder accounts for 130 parts, and nano-titanium dioxide accounts for 2 parts, and nano silver accounts for 0 part.Irradiation is specially：Irradiation energy is
3MeV, electric current 15mA, irradiation time 30min.Electrostatic spinning concrete technology is：Using roller as wire drawing device, syringe needle with
Distance is 11cm, drum rotation speed 1000rpm between roller, and voltage difference is 12V between syringe needle and roller.
Embodiment 7
Dressing is prepared by the following method：PVA powder, PAAS powder and polylactic acid are provided；PVA powder is dissolved
In deionized water, the first solution is obtained；Polylactic acid is dissolved in deionized water, the second solution is obtained；PAAS powder is molten
Solution obtains third solution in hexafluoroisopropanol；The first solution and the second solution are added dropwise into third solution, and carries out first
Stirring, obtains the 4th solution；It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out
Second stirring, obtains the 5th solution；It is irradiated using the 5th solution of electron beam pair, obtains dilute colloidal sol；Dilute colloidal sol is poured into quiet
Electrospun syringe, and prepare dressing using electrospinning process.In the first solution, the mass percent of PVA powder is 5%.
In the second solution, the mass percent of polylactic acid is 4%.In third solution, the mass percent of PAAS powder is 9%.
In parts by weight, in the 4th solution, PVA powder accounts for 11 parts, and polylactic acid accounts for 4 parts, and PAAS powder accounts for 8 parts.In parts by weight, exist
In 5th solution, PVA powder accounts for 110 parts, and nano-titanium dioxide accounts for 4 parts, and nano silver accounts for 2 parts.Irradiation is specially：Irradiation energy is
1.5MeV, electric current 8mA, irradiation time 15min.Electrostatic spinning concrete technology is：Using roller as wire drawing device, syringe needle with
Distance is 15cm, drum rotation speed 1500rpm between roller, and voltage difference is 20V between syringe needle and roller.
Tensile strength and comfort test are carried out to embodiment 1-7, the results are shown in Table 1, is observed for convenience, all result phases
Data processing has been carried out for embodiment 1.
Table 1
| Tensile strength | Comfort level | |
| Embodiment 1 | 100% | It is good |
| Embodiment 2 | 104% | It is good |
| Embodiment 3 | 103% | It is good |
| Embodiment 4 | 78% | Generally |
| Embodiment 5 | 83% | Generally |
| Embodiment 6 | 67% | Difference |
| Embodiment 7 | 65% | Difference |
The description of the aforementioned specific exemplary embodiment to the present invention is in order to illustrate and illustration purpose.These descriptions
It is not wishing to limit the invention to disclosed precise forms, and it will be apparent that according to the above instruction, can much be changed
And variation.The purpose of selecting and describing the exemplary embodiment is that explaining the specific principle of the present invention and its actually answering
With so that those skilled in the art can realize and utilize the present invention a variety of different exemplary implementation schemes and
Various chooses and changes.The scope of the present invention is intended to be limited by claims and its equivalents.
Claims (8)
1. a kind of dressing for testing patients with gestational diabetes blood glucose, it is characterised in that：The dressing is by the following method
It prepares：
PVA powder, PAAS powder and polylactic acid are provided；
The PVA powder is dissolved in deionized water, the first solution is obtained；
The polylactic acid is dissolved in deionized water, the second solution is obtained；
The PAAS powder is dissolved in hexafluoroisopropanol, third solution is obtained；
First solution and second solution are added dropwise into the third solution, and carries out the first stirring, obtains the 4th
Solution；
It is slowly added to the mixing suspension of nano-titanium dioxide and nano silver into the first solution, and carries out the second stirring, obtains
5th solution；
The 5th solution is irradiated using electron beam, obtains dilute colloidal sol；
Dilute colloidal sol is poured into electrostatic spinning syringe, and the dressing is prepared using electrospinning process.
2. the dressing as described in claim 1 for testing patients with gestational diabetes blood glucose, it is characterised in that：Described first
In solution, the mass percent of the PVA powder is 4-6%.
3. the dressing as described in claim 1 for testing patients with gestational diabetes blood glucose, it is characterised in that：Described second
In solution, the mass percent of the polylactic acid is 3-5%.
4. the dressing as described in claim 1 for testing patients with gestational diabetes blood glucose, it is characterised in that：In the third
In solution, the mass percent of the PAAS powder is 8-10%.
5. the dressing as described in claim 1 for testing patients with gestational diabetes blood glucose, it is characterised in that：With parts by weight
Meter, in the 4th solution, the PVA powder accounts for 10-12 parts, and the polylactic acid accounts for 3-5 parts, and the PAAS powder accounts for 5-10
Part.
6. the dressing as described in claim 1 for testing patients with gestational diabetes blood glucose, it is characterised in that：With parts by weight
Meter, in the 5th solution, the PVA powder accounts for 100-120 parts, and the nano-titanium dioxide accounts for 3-6 parts, the nano silver
Account for 1-3 parts.
7. the dressing as described in claim 1 for testing patients with gestational diabetes blood glucose, it is characterised in that：The irradiation tool
Body is：Irradiation energy is 1-2MeV, electric current 5-10mA, irradiation time 10-20min.
8. the dressing as described in claim 1 for testing patients with gestational diabetes blood glucose, it is characterised in that：Electrostatic spinning has
Body technology is：Using roller as wire drawing device, distance is 10-12cm, drum rotation speed 900- between syringe needle and roller
1200rpm, voltage difference is 10-15V between syringe needle and roller.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810440809.4A CN108642718B (en) | 2018-05-10 | 2018-05-10 | It is a kind of for testing the dressing of patients with gestational diabetes blood glucose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810440809.4A CN108642718B (en) | 2018-05-10 | 2018-05-10 | It is a kind of for testing the dressing of patients with gestational diabetes blood glucose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108642718A true CN108642718A (en) | 2018-10-12 |
| CN108642718B CN108642718B (en) | 2019-11-26 |
Family
ID=63753910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810440809.4A Expired - Fee Related CN108642718B (en) | 2018-05-10 | 2018-05-10 | It is a kind of for testing the dressing of patients with gestational diabetes blood glucose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108642718B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006137588A1 (en) * | 2005-06-22 | 2006-12-28 | Nitto Boseki Co., Ltd. | Oil-absorbing mat and method of treating oil-absorbing mat |
| CN101161705A (en) * | 2006-10-13 | 2008-04-16 | 中国科学院化学研究所 | Functional polymer nano composite material and preparation method and uses thereof |
| CN102600018A (en) * | 2012-03-31 | 2012-07-25 | 华南理工大学 | Medical dressing with cooling function and wound healing prompting function and preparation method of medical dressing |
| CN106930007A (en) * | 2017-02-21 | 2017-07-07 | 东华大学 | Micro nanometer fiber composite membrane with the unidirectional conducting power of moisture and preparation method thereof |
| CN107051221A (en) * | 2017-04-27 | 2017-08-18 | 舒尔环保科技（合肥）有限公司 | A kind of antibiotic property air-filtering membrane and its manufacture craft |
| CN107254742A (en) * | 2017-07-03 | 2017-10-17 | 河南工程学院 | The composite fiber web of polyvinyl alcohol/sericin containing Nano Silver for medical dressing |
| CN107602977A (en) * | 2017-09-14 | 2018-01-19 | 浙江润阳新材料科技股份有限公司 | A kind of antimildew and antibacterial expanded material and preparation method thereof |
-
2018
- 2018-05-10 CN CN201810440809.4A patent/CN108642718B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006137588A1 (en) * | 2005-06-22 | 2006-12-28 | Nitto Boseki Co., Ltd. | Oil-absorbing mat and method of treating oil-absorbing mat |
| CN101161705A (en) * | 2006-10-13 | 2008-04-16 | 中国科学院化学研究所 | Functional polymer nano composite material and preparation method and uses thereof |
| CN102600018A (en) * | 2012-03-31 | 2012-07-25 | 华南理工大学 | Medical dressing with cooling function and wound healing prompting function and preparation method of medical dressing |
| CN106930007A (en) * | 2017-02-21 | 2017-07-07 | 东华大学 | Micro nanometer fiber composite membrane with the unidirectional conducting power of moisture and preparation method thereof |
| CN107051221A (en) * | 2017-04-27 | 2017-08-18 | 舒尔环保科技（合肥）有限公司 | A kind of antibiotic property air-filtering membrane and its manufacture craft |
| CN107254742A (en) * | 2017-07-03 | 2017-10-17 | 河南工程学院 | The composite fiber web of polyvinyl alcohol/sericin containing Nano Silver for medical dressing |
| CN107602977A (en) * | 2017-09-14 | 2018-01-19 | 浙江润阳新材料科技股份有限公司 | A kind of antimildew and antibacterial expanded material and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 郭世伟等: "电纺含银纳米粒子复合纤维的制备及应用", 《化学进展》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108642718B (en) | 2019-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE202016000120U1 (en) | System for detecting signals of the pulse diagnosis and detection device of the pulse diagnosis | |
| CN105199430B (en) | Epithelial tissue staining reagent and preparation method thereof | |
| CN105232054A (en) | Human body endocrine system health risk early warning system | |
| CN108642718B (en) | It is a kind of for testing the dressing of patients with gestational diabetes blood glucose | |
| CN101574556A (en) | Osteoporosis therapy system based on variable Helmholtz coils | |
| CN107997790A (en) | A kind of minimally invasive comfort urinary incontinence sling apparatus and its application | |
| CN204765919U (en) | Trigeminal nerve direction finder based on CT guide | |
| CN206166968U (en) | Pressure monitoring type cardiac pacemaker bag hemostat through compression | |
| CN102068744A (en) | Electroencephalic monitoring-sensory stimulation waking integrated therapeutic apparatus | |
| CN208339576U (en) | Ultrasonic guidance S3 sacral nerve positioning device | |
| CN208756037U (en) | A kind of minimally invasive comfort urinary incontinence sling apparatus | |
| CN205697874U (en) | A kind of collapsible stomach wall pulling device | |
| O’Reilly et al. | Change in quality of life scores in incontinence patients following an intervention of external electrical stimulation as determined by the Kings Health Questionnaire | |
| CN205849648U (en) | Tinnitus sound therapentic device | |
| Kubista et al. | Electro-acupuncture's influence on the closure mechanism of the female urethra in incontinence | |
| CN204428487U (en) | A kind of surgical patch for the treatment of pelvic floor prolapse | |
| CN205268826U (en) | Amazing system of sacral nerve | |
| CN204995533U (en) | High comfort level lacks blood pre -adaptation training appearance | |
| CN208610830U (en) | A kind of fetal heart monitoring auxiliary device and fetal heart monitoring device | |
| CN204016559U (en) | Artificial cochlea implanting device with location structure | |
| CN201263674Y (en) | Angiocarpy endoscope | |
| CN221534229U (en) | Cerebral vessel shape-changing remodelling device | |
| CN201290996Y (en) | Osteoporosis treatment system based on variant Helmholtz magnetic coil | |
| CN201481441U (en) | CT scanning auxiliary frame for joint of lower extremity | |
| CN207084810U (en) | A kind of bed sufferer diagnosis and treatment device of feeling the pulse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191126 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |